SOD1 and amyotrophic lateral sclerosis: Although mice expressing high levels of human WT SOD1 develop clinical signs of ALS, including paresis, the age at which WT mice reach end-stage is approximately 2 times longer than mice that express comparable levels of G93A fALS SOD1 (367±56 days vs 155±9 days) [47].